Orion Market Research Pvt. Ltd. info@omrglobal.com +91 780-304-0404

Advancement in technologies enables to create modern day world led by introduction of new smart gadgets that have optimized business operations and eased lives. New technologies and development has significantly contributed in shaping modern day businesses and day to day activities through innovation, contentedness and R&D. Recent advance technology in domains such as automotive, healthcare, chemical and ICT have simplified complex business processes and enhanced time and cost efficiency.

Latest Press Releases
Several R&D Activities Coupled with New Product Launches is Providing a Thrust to the Global Chemotherapy-Induced Neutropenia Treatment Market Growth
Published: Apr 2022
The global chemotherapy-induced neutropenia treatment market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). One of the major factors that are fuelling the market is the increased use of chemotherapy in the treatment of neutropenia. The colony-stimulating factor therapy is heavily being used for the treatment of cancer. The added benefit of the colony-stimulating factor is the ability to help bone marrow in developing white blood cells. For instance, in June 2019, Amgen Inc. and Allergan PLC announced that the U.S. Food and Drug Administration (FDA) has approved KANJINTI  for all approved indications of the reference product, Herceptin for the treatment of HER2-overexpressing adjuvant and metastatic breast cancer. 
Technological Advancements Relating to Defense Field Pours Large Investment on R&D is Driving the Growth of the Combat System Integration market
Published: Apr 2022
The global combat system integration market is anticipated to grow at a considerable CAGR of 34.0% during the forecast period (2022-2028). Growing technological advancements catering for several and large investments spurring the R&D activities across the globe is the major factor contributing towards the growth of the combat system integration market. Among all the industries, the aerospace and defense industry of economies such as India, China, Australia, and others is likely to invest heavily in various R&D activities which will further drive the growth.
Expansion Of High-Quality Hypertension Therapy is Expected to Fuel the Global Benazepril Market
Published: Apr 2022
The global benazepril market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The major factor that drives the global benazepril market is a rise in awareness related to complications associated with hypertension which fuels the growth of the market. Moreover, the increase in the geriatric population and sedentary lifestyle act as key drivers of the global market. However, patent expirations of benazepril hinder the growth of the antihypertensive market.
Technological Advancements and Key Acquisitions is Expected to Drive the Global Botulinum Toxin Injection Market
Published: Apr 2022
The global botulinum toxin injection market is anticipated to grow at a significant CAGR of 5.9% during the forecast period. Advancements in augmented reality in aesthetic procedures are anticipated to drive the market in the coming years. Augmented reality is computer-generated images on a screen with a real object or a scene. The researchers use high definition 3D camera to capture the image of the facial surface and computed tomography to obtain digital information on the underlying facial bones. Moreover , augmented reality c is expected to act as a guide to planning, performing, and evaluating the results of facial reconstruction. Furthermore, migraine is anticipated as the most prevalent symptom globally. 
Several FDA Approval Boosting the Growth of Global NT Growth Factor Receptor Market
Published: Apr 2022
The global NT growth factor receptor market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, new product launches, FDA approval, research, and development of new drugs to stay competitive in the market. For instance, in May 2021, FDA grants approval to amivantamab-vmjw, which is a bi-specific antibody directed against epidermal growth factor and MET receptors, for adult patients with locally advanced or metastatic non-small cell lung cancer with epidermal growth factor receptors.
New Launches and Approvals by Key Players to Booth the Growth of the Vasculitis Drug Market
Published: Apr 2022
The global vasculitis drug market is projected to grow at a significant CAGR during the forecast period (2022-2028). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launch, and product innovation to remain competitive in the marketplace. For instance, in January 2022the European Commission approved Tavneos in combination with a rituximab or cyclophosphamide regimen for the treatment of adult patients with severe, active granulomatosis polyangiitis (GPA) or microscopic polyangiitis (MPA), the two main forms of ANCA-associated vasculitis, according to Vifor Fresenius Medical Care Renal Pharma (VFMCRP). 
Adoption of Orally Disintegrating Tablets and Increasing Cases of Several Diseases are Expected to Propel the Growth of The Global Super Disintegrant Drugs Market.
Published: Apr 2022
The global super disintegrant market is anticipated to grow at a considerable SGR during the forecast year. Super disintegrates are the chemical agent used in medicines for the treatment of various diseases. It works by dissolving quickly in water or saliva when taken directly into the mouth. The major factor driving the growth of the market is the development of generic medicines and the growing adoption of orally disintegrating tablets (ODTs) among patients. Orally disintegrating tablets (ODTs) are tablets made using super disintegrants that dissolve in water very quickly and efficiently provide treatment to the affected area. 
The Increasing Prevalence of Infectious Diseases is driving the Global Pyrogen Testing Market
Published: Apr 2022
The global Pyrogen Testing market is anticipated to grow at a considerable CAGR of around 8.5%during the forecast period (2022-2028). The rising prevalence of infectious diseases such as HIV/AIDS, Infectious mononucleosis., Influenza (flu), Chickenpox, Common cold among others across the globe, respect to this the demand for pyrogen testing techniques that are utilized for endotoxin and microbial identification are propelling thereby boosting the pyrogen testing market growth. As per the U.S. Department of Health & Human Services, here were approximately 37.7 million people across the globe with HIV in 2020. Of these, 36 million were adults and 1.7 million were children aged 0-14 years.
Growing Preference for Plant-Based Diet Products is Driving in the Global Plant-Based Protein Supplement Market
Published: Apr 2022
The global Plant-Based Protein Supplement market is anticipated to grow at a considerable CAGR of around 8.1 % during the forecast period (2022-2028). Rising awareness about animal welfare and also environmental sustainability pushes customers to shift towards it and adopt a plant-based diet. Customers currently are more health-conscious and perception is also evolving that plant base products are safe and more healthy than animal-oriented products. Furthermore, the increasing vegan population and increasing preference for vegetarian diets is propelling manufacturers to develop innovative sources of plant-based proteins. 
Recent Trends including Adoption of Nano technology and Medicine to boost the Nano Pharmaceutical Market.
Published: Apr 2022
The global nano pharmaceutical market is projected to grow at a significant CAGR during the forecast period (2022-2028). Nano pharmaceutical is a medical application for nanotechnology ranging from the medical use of nanomaterials and biological devices to nano-electronic biosensors. A major factor contributing to market growth is the development of new drug delivery technologies and the increasing adoption of nanomedicine and nanotechnologies across various applications worldwide.